WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy

Phase 1

Terminated

Conditions: Neoplasms

Interventions: Biological: trivalent influenza vaccine

First Posted Date: 2012-09-28

Last Posted Date: 2018-08-31

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 21

Registration Number: NCT01695733

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging

Phase 1

Completed

Conditions: Depression
Anxiety Disorders

Interventions: Behavioral: MBSR
Behavioral: control (health education)

First Posted Date: 2012-09-26

Last Posted Date: 2014-07-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 103

Registration Number: NCT01693874

Locations: 🇺🇸
University of California San Diego, San Diego, California, United States
🇺🇸
Washington University School of Medicine, St Louis, Missouri, United States

Does Protein Restriction Inhibit Prostrate Cancer Growth

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Other: Protein restrictive diet

First Posted Date: 2012-09-25

Last Posted Date: 2021-03-26

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 65

Registration Number: NCT01692587

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

The Prevention of Delirium and Complications Associated With Surgical Treatments Multi Center Clinical Trial

Phase 3

Completed

Conditions: Delirium

Interventions: Drug: Ketamine (0.5 mg/kg)
Drug: Ketamine (1 mg/kg)
Drug: Normal Saline (placebo)

First Posted Date: 2012-09-24

Last Posted Date: 2018-06-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 746

Registration Number: NCT01690988

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer

Phase 3

Terminated

Conditions: Oropharyngeal Neoplasms

Interventions: Radiation: Intensity-modulated radiation therapy (IMRT)
Drug: Cisplatin

First Posted Date: 2012-09-18

Last Posted Date: 2020-11-25

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 42

Registration Number: NCT01687413

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States

Genomic Predictors of Decitabine Response in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

Phase 2

Completed

Conditions: Myelodysplastic Syndromes
Leukemia, Myeloid, Acute

Interventions: Drug: decitabine

First Posted Date: 2012-09-18

Last Posted Date: 2018-10-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 114

Registration Number: NCT01687400

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Dietary Nitrate for Heart Failure

Phase 1

Completed

Conditions: Heart Failure
Hypertension, Pulmonary

Interventions: Dietary Supplement: placebo
Dietary Supplement: Beetroot Juice (BRJ)

First Posted Date: 2012-09-10

Last Posted Date: 2024-12-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 17

Registration Number: NCT01682356

Locations: 🇺🇸
Indiana University Purdue University Indianapolis, Indianapolis, Indiana, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies

Phase 1

Completed

Conditions: Adenocarcinoma
Pancreatic Neoplasms

Interventions: Drug: MLN8237
Drug: nab-Paclitaxel

First Posted Date: 2012-09-03

Last Posted Date: 2018-01-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 34

Registration Number: NCT01677559

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer

Phase 2

Completed

Conditions: Breast Neoplasms

Interventions: Drug: Neratinib
Procedure: Tumor biopsy
Drug: Fulvestrant
Drug: Trastuzumab
Procedure: Research blood sample

First Posted Date: 2012-08-22

Last Posted Date: 2022-04-15

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 56

Registration Number: NCT01670877

Locations: 🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada
🇺🇸
University of Southern California Keck School of Medicine, Los Angeles, California, United States
🇺🇸
University of Miami Hospital and Clinics, Miami, Florida, United States

and more 14 locations

Radiofrequency Ablation in Treating Patients With Liver Cancer (Hepatocellular Carcinoma)

Phase 2

Withdrawn

Conditions: Carcinoma, Hepatocellular

Interventions: Procedure: radiofrequency ablation
Procedure: laparoscopy

First Posted Date: 2012-08-21

Last Posted Date: 2014-07-16

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT01669668

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy